Karen Stephens was later diagnosed with bowel cancer and has urged others not to risk their lives because of 'pride' ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and ...

The College of Nurses of Ontario (CNO) welcomes the Ontario government's new bill to promote labour mobility in Canada, so we can continue to enable more nurses to provide safe ...

Stroke is the fourth leading cause of death among Hispanic men and the third leading cause for Hispanic women in the United States. Yet, according to CDC reports, only 58% of Hispanic adults can ...

has achieved unprecedented results in the treatment of rectal cancer, marking an incredible milestone in oncology. The trial, which utilized the immunotherapy drug dostarlimab (called Jemperli ...

In March 2025, Coordination Pharmaceuticals Inc. announced a phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or ...

Earlier this month, new immunotherapy dostarlimab was one of the latest drugs to be fast-tracked through the CDF, offering hundreds of women with advanced endometrial cancer the hope of ...

with a phase 3 trial win for immunotherapy Jemperli in endometrial cancer and the start of a review in the EU for myelofibrosis drug momelotinib. PD-1 inhibitor Jemperli (dostarlimab) hit the mark ...

The drugmaker remains convinced of the potential of the drug, however, and has just reported results of a trial comparing Jemperli (dostarlimab ... non-small cell lung cancer (NSCLC) that has ...

Immunotherapy drugs approved for advanced endometrial cancer include: Dostarlimab (Jemperli) Durvalumab (Imfinzi) Pembrolizumab (Keytruda) Combined with chemotherapy, treatment with immune ...

NEW YORK – Elevation Oncology last week said it will discontinue development of its claudin (CLDN) 18.2-targeted antibody-drug conjugate (ADC) EO-3021 in gastric cancer based on disappointing ...